AZD0022
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD0022, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation [Phase 1]